EVAXION BIOTECH A S - ADS (EVAX)

CUSIP: 29970R105

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / ADS
Total 13F shares
678,270
Share change
-399,144
Total reported value
$2,060,000
Put/Call ratio
3.6%
Price per share
$3.05
Number of holders
11
Value change
-$1,258,575
Number of buys
6
Number of sells
7

Quarterly Holders Quick Answers

What is CUSIP 29970R105?
CUSIP 29970R105 identifies EVAX - EVAXION BIOTECH A S - ADS in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of EVAXION BIOTECH A S - ADS (EVAX) as of Q1 2022

As of 31 Mar 2022, EVAXION BIOTECH A S - ADS (EVAX) was held by 11 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 678,270 shares. The largest 10 holders included LUMINUS MANAGEMENT LLC, Telemetry Investments, L.L.C., Kepos Capital LP, TWO SIGMA INVESTMENTS, LP, CITADEL ADVISORS LLC, MORGAN STANLEY, ETF MANAGERS GROUP, LLC, CITIGROUP INC, UBS Group AG, and Steward Partners Investment Advisory, LLC. This page lists 11 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.